Gonorrhea (Infectious Disease) Pipeline Guide, H2 2018 Summary Latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea - Pipeline Review, H2 2018, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape. Gonorrhea is an infection caused by a sexually transmitted bacterium that can infect both males and females. Gonorrhea most often affects the urethra, rectum or throat. In females, gonorrhea can also infect the cervix. Gonorrhea Symptoms The symptoms may include painful urination, pus-like discharge from the tip of the penis, increased vaginal discharge, painful urination, abdominal pain and pelvic pain. Treatment includes antibiotics. Report Highlights Latest Pharmaceutical market research report on “Gonorrhea - Pipeline Review, H2 2018” provides comprehensive information on the therapeutics under development for Gonorrhea (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The pipeline guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
To know more in detailed, Browse Full Report: Gonorrhea - Pipeline Review, H2 2018 Or Request a sample report: https://www.jsbmarketresearch.com/sample-request/gonorrhea-pipeline-r eview-h2-2018 Gonorrhea - Companies Involved in Therapeutics Development ● Debiopharm International SA ● Entasis Therapeutics Inc